Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Johnson & Johnson

J. Heymach, M. Das

Management and Proactive Care of Adverse Events Associated with Loca…

Johnson & Johnson

J. Sabari, A. Spira

Lung Cancer Screening and Approach to the Lung Nodule

Brigham and Women's Hospital

A. Ramaswamy

Key to Successful Lung Cancer Screening and Lung Nodule Program

University of Colorado Department of Medicine

N. Thomas

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

Mediastinal Staging of Lung Cancer

MI&T Congressi

R. Trisolini

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

Lung Cancer Screening in Primary Care

UNC Lineberger Comprehensive Cancer Center

N. Robertson

The Role of Molecular Biomarkers for Lung Nodule Evaluation

Cleveland Clinic Respiratory Institute

P. J Mazzone

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Total Health

S. Kazmi

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Diagnostics in Lung Cancer: A Comprehensive Discussion - Best of Lun…

Total Health

T. Boyle

Clinical Application of ctDNA Monitoring in Resected Early NSCLC

Arianna Marinello

Respiratory Tract, EBUS, Molecular Biomarker Testing in Non-Small Ce…

Houston Methodist

S. Roy-Chowdhuri

Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC

GRACE

A. Desai

The Future of Lung Cancer Care

Yale Cancer Center

M. Davies

The Importance of Liquid Biopsy in Advanced NSCLC

Rajat Thawani

Diagnosis and Staging of Lung Cancer in the Era of Advanced Diagnost…

Cleveland Clinic Respiratory Institute

F. Almeida